A Cost-Effective De-escalation Strategy in Advanced Melanoma A Cost-Effective De-escalation Strategy in Advanced Melanoma
Response-adapted de-escalation of ipilimumab in patients with advanced melanoma has the potential to lower healthcare costs.Medscape Medical News
Source: Medscape Radiology Headlines - Category: Radiology Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Healthcare Costs | Hematology | Melanoma | Radiology | Skin Cancer | Yervoy